Literature DB >> 14994305

(1)H magnetic resonance spectroscopy of preinvasive and invasive cervical cancer: in vivo-ex vivo profiles and effect of tumor load.

Marrita M Mahon1, I Jane Cox, Roberto Dina, W Patrick Soutter, G Angus McIndoe, Andreanna D Williams, Nandita M deSouza.   

Abstract

PURPOSE: To compare in vivo (1)H magnetic resonance (MR) spectra of preinvasive and invasive cervical lesions with ex vivo magic angle spinning (MAS) spectra of intact biopsies from the same subjects and to establish the effects of tumor load in the tissue sampled on the findings.
MATERIALS AND METHODS: A total of 51 subjects (nine with normal cervix, 10 with cervical intraepithelial neoplasia [CIN], and 32 with cervical cancer) underwent endovaginal MR at 1.5 T. Single-voxel (3.4 cm(3)) (1)H MR spectra were acquired and voxel tumor load was calculated (tumor volume within voxel as a percentage of voxel volume). Resonances from triglycerides -CH(2) and -CH(3) and choline-containing compounds (Cho) were correlated with voxel tumor load. Biopsies analyzed by (1)H MAS-MR spectroscopy (MRS) had metabolite levels correlated with tumor load in the sample at histology.
RESULTS: In vivo studies detected Cho in normal, CIN, and cancer patients with no significant differences in levels (P = 0.93); levels were independent of voxel tumor load. Triglyceride -CH(2) and -CH(3) signals in-phase with Cho were present in 77% and 29%, respectively, of cancer subjects (but not in normal women or those with CIN), but did not correlate with voxel tumor load. Ex vivo cancer biopsies showed levels of triglycerides -CH(2) and -CH(3) and of Cho that were significantly greater than in normal or CIN biopsies (P < 0.05); levels were independent of the tumor load in the sample. The presence of -CH(2) in vivo predicted the presence of cancer with a sensitivity and specificity of 77.4% and 93.8% respectively, positive (PPV) and negative (NPV) predictive values were 96% and 68.2%; for -CH(2) ex vivo, sensitivity was 100%; specificity, 69%; PPV, 82%; and NPV, 100%.
CONCLUSION: Elevated lipid levels are detected by MRS in vivo and ex vivo in cervical cancer and are independent of tumor load in the volume of tissue sampled. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14994305     DOI: 10.1002/jmri.20012

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  13 in total

1.  In vivo detection of metabolic changes by 1H-MRS in the DEN-induced hepatocellular carcinoma in Wistar rat.

Authors:  Wei-Dong Zhao; Sheng Guan; Kang-Rong Zhou; Hui Li; Wei-Jun Peng; Feng Tang; Zhong-Wei Chen
Journal:  J Cancer Res Clin Oncol       Date:  2005-10-20       Impact factor: 4.553

2.  Newer Diagnostic Methods in Oncology.

Authors:  L Goyal; S Hingmire; Purvish M Parikh
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 3.  Applications of high-resolution magic angle spinning MRS in biomedical studies II-Human diseases.

Authors:  Christopher Dietz; Felix Ehret; Francesco Palmas; Lindsey A Vandergrift; Yanni Jiang; Vanessa Schmitt; Vera Dufner; Piet Habbel; Johannes Nowak; Leo L Cheng
Journal:  NMR Biomed       Date:  2017-09-15       Impact factor: 4.044

Review 4.  Focus on the glycerophosphocholine pathway in choline phospholipid metabolism of cancer.

Authors:  Kanchan Sonkar; Vinay Ayyappan; Caitlin M Tressler; Oluwatobi Adelaja; Ruoqing Cai; Menglin Cheng; Kristine Glunde
Journal:  NMR Biomed       Date:  2019-06-11       Impact factor: 4.044

5.  Can magnetic resonance spectroscopy differentiate endometrial cancer?

Authors:  Jie Zhang; Shifeng Cai; Changzhong Li; Xichao Sun; Xue Han; Chunrun Yang; Caixia Fu; Qingwei Liu; Yinghui Xin; Yuanyuan Zong
Journal:  Eur Radiol       Date:  2014-06-06       Impact factor: 5.315

6.  Preliminary observations and clinical value of lipid peak in high-grade uterine sarcomas using in vivo proton MR spectroscopy.

Authors:  Mayumi Takeuchi; Kenji Matsuzaki; Masafumi Harada
Journal:  Eur Radiol       Date:  2013-06-06       Impact factor: 5.315

Review 7.  MR-visible lipids and the tumor microenvironment.

Authors:  E James Delikatny; Sanjeev Chawla; Daniel-Joseph Leung; Harish Poptani
Journal:  NMR Biomed       Date:  2011-04-27       Impact factor: 4.044

8.  Evaluation of diffusion-weighted imaging (DWI) and MR spectroscopy (MRS) as early response biomarkers in cervical cancer patients.

Authors:  Stefania Rizzo; Valentina Buscarino; Daniela Origgi; Paul Summers; Sara Raimondi; Roberta Lazzari; Fabio Landoni; Massimo Bellomi
Journal:  Radiol Med       Date:  2016-07-02       Impact factor: 3.469

Review 9.  Current opportunities and challenges of magnetic resonance spectroscopy, positron emission tomography, and mass spectrometry imaging for mapping cancer metabolism in vivo.

Authors:  Gigin Lin; Yuen-Li Chung
Journal:  Biomed Res Int       Date:  2014-03-03       Impact factor: 3.411

10.  Role of 3T multiparametric-MRI with BOLD hypoxia imaging for diagnosis and post therapy response evaluation of postoperative recurrent cervical cancers.

Authors:  Abhishek Mahajan; Reena Engineer; Supriya Chopra; Umesh Mahanshetty; S L Juvekar; S K Shrivastava; Naresh Desekar; M H Thakur
Journal:  Eur J Radiol Open       Date:  2015-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.